The neuromuscular and multisystem features of RYR1-related malignant hyperthermia and rhabdomyolysis: A study

Luuk R van den Bersselaar1,2, Nick Kruijt2, Gert-Jan Scheffer3

  • 1Malignant Hyperthermia Investigation Unit, Department of Anesthesiology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.

Medicine
|August 20, 2021
PubMed
Abstract

Insights

This study investigates the continuous symptoms and multisystem effects of RYR1-related disorders, including Malignant Hyperthermia (MH) and Exertional Rhabdomyolysis (ERM). Findings will improve diagnosis and personalized care for these rare neuromuscular conditions.

Area of Science:

  • Neurology
  • Immunology
  • Genetics

Background:

  • Malignant hyperthermia (MH) and exertional rhabdomyolysis (ERM) are often viewed as episodic, triggered events in individuals with RYR1 variants.
  • Emerging evidence suggests a continuum between RYR1-related congenital myopathies and MH/ERM, with potential non-neuromuscular manifestations.
  • RYR1 variants may be associated with a mild bleeding disorder and immune system dysregulation, warranting further investigation.

Purpose of the Study:

  • To comprehensively examine the continuous disease manifestations and their impact on daily life in patients with RYR1-related MH and ERM.
  • To explore the potential multisystem involvement, including immunological aspects, associated with these RYR1-related conditions.
  • To establish a well-characterized patient cohort for future research into RYR1-related disorders.

Main Methods:

  • A multi-part study including online questionnaires, clinical observation, muscle imaging (ultrasound, MRI), and immunological assessments.
  • Questionnaires administered thrice yearly to evaluate disease impact, daily activities, fatigue, and pain.
  • Immunological studies involve in vitro stimulation of peripheral blood cells to investigate the immune system's role.

Main Results:

  • This section is to be filled upon study completion.

Conclusions:

  • The study aims to enhance understanding of the full spectrum of RYR1-related neuromuscular and multisystem features.
  • Expected outcomes include improved recognition of RYR1-related symptoms, better patient counseling, and personalized treatment strategies.
  • New insights into the immune system's role in the pathophysiology of MH and ERM are anticipated.

Related Concept Videos